Original language | English |
---|---|
Pages (from-to) | 415-416 |
Number of pages | 2 |
Journal | Radiotherapy and Oncology |
Volume | 114 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Mar 2015 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Radiotherapy and Oncology, Vol. 114, No. 3, 01.03.2015, p. 415-416.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer
T2 - Long-term results of the UNICANCER ACCORD 16 phase II trial
AU - Levy, Antonin
AU - Azria, David
AU - Pignon, Jean Pierre
AU - Delarochefordiere, Anne
AU - Martel-Lafay, Isabelle
AU - Rio, Emmanuel
AU - Malka, David
AU - Conroy, Thierry
AU - Miglianico, Laurent
AU - Becouarn, Yves
AU - Malekzadeh, Katty
AU - Leclercq, Julie
AU - Juzyna, Beata
AU - Ezra, Patrick
AU - Lemanski, Claire
AU - Deutsch, Eric
N1 - Funding Information: This study was funded by a medical Grant from Merck KGaA . Merck KGaA have reviewed this manuscript but the views and opinions described do not necessarily reflect those of Merck KGaA.
PY - 2015/3/1
Y1 - 2015/3/1
UR - http://www.scopus.com/inward/record.url?scp=84927571118&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2015.02.008
DO - 10.1016/j.radonc.2015.02.008
M3 - Letter
C2 - 25769380
AN - SCOPUS:84927571118
SN - 0167-8140
VL - 114
SP - 415
EP - 416
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 3
ER -